home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Valves in the Heart of the Big Apple: Evaluation & Management of Valvular Heart Diseases 2002  
  September 21, 2001

Cardiovascular Research

 
     
  Weill Medical College of Cornell University, New York City
May 2- 3, 2002


Wednesday, May 1, 2002

Registration

Thursday, May 2, 2002

Registration and Continental Breakfast

Daniel J. Williford, M.D., Ph.D.
President, American College of Cardiology, New York State Chapter and Immediate Past President, New York Cardiological Society of the American College of Cardiology, New York State Chapter

Introduction and Symposium Goals
Jeffrey S. Borer, MD; O. Wayne Isom, M.D.

OVERVIEW
Chairman: O. Wayne Isom, M.D.

THE HOWARD GILMAN FOUNDATION LECTURE
Where have we come from and where are we going? Valve disease management past, present and future
Joseph K. Perloff, M.D.

The epidemiology of valvular heart diseases: the problem is growing
Phyllis Supino, Ed.D.

Echocardiographic techniques for estimation of valvular dysfunction: measurement and importance of regurgitant volume and diastolic performance, detection of mitral valve prolapse
Jamil Tajik, M.D.

Post-cardiotomy support strategies after valve surgery
Mehmet Oz, M.D.

Prevention of perioperative stroke: perspectives on intra-operative pump pressures and post-operative anticoagulation
Karl Krieger, M.D.

Panel Discussion/Q & A
Karl Krieger, Chairman; Drs. Supino, Tajik, Oz, Perloff, Isom, Borer

Coffee Break

CONGENITAL LESIONS WITH VALVULAR COMPONENTS
Chairman: John Lamberti, M.D.

Tetralogy of Fallot: current management and effect of pulmonic insufficiency on natural course after repair
John Lamberti, M.D.

Mitral and tricuspid regurgitation associated with shunt lesions: endocardial cushion defects

Embryology, range of pathology and functional deficits
Rubin Cooper, M.D.

Techniques and long-term results of surgical intervention
Jan Quagebeur, M.D.

Pulmonic stenosis: natural history, indications for valvotomy, choice of procedure
William Z. Hillenbrand, M.D.

Panel Discussion/Q & A
Joseph K. Perloff, M.D., Chairman; Drs. Lamberti, Cooper, Quagebeur, Gold

Lunch

Unrecognized valvular disease and sudden death in the athlete

Arthur (“Archie”) Roberts, M.D.
President, The Living Heart Foundation and
Director, National Cardiac Screening Lifestyle Initiative
(Former Chief, Cardiac Surgery, Northwestern University, University of Florida, Boston University, and last football All-America produced by Columbia University [quarterback, 1965])


CORONARY OBSTRUCTIONS AND NON-ISCHEMIC VALVE DISEASE
Chairman: Robert O. Bonow, M.D.

Impact of concomitant CAD on natural history when aortic and/or mitral valve diseases are present
Robert O. Bonow, M.D.

Threshold for additional surgery for aortic or non-ischemic mitral valve disease when CABG is the primary surgical indication
Aubrey Galloway, M.D.

Selection of techniques for valve surgery and CABG: impact of combined procedures involving aortic or mitral valve
Lawrence Cohn, M.D.

Panel Discussion/Q & A Lawrence Cohn, M.D., Chairman; Drs. Isom, Bonow, Gold/Galloway

Coffee Break

MITRAL VALVE DISEASE I
Mark Starling, M.D.

Is prophylactic beta blockade appropriate in MR? Impact of cellular pathophysiology
Mark Starling, M.D.

Do follow-up data now support use of tissue valves in the mitral position before age 80?
Timothy Gardner, M.D.

Indications for mitral valve surgery in the asymptomatic patient: do these differ in the presence vs the absence of flail leaflet?
Maurice Enriquez-Sarano, M.D.

Mitral valve repair for ischemic mitral insufficiency: techniques and results
Delos Cosgrove, M.D.

When should tricuspid valve replacement/repair accompany mitral valve surgery?
Jeff Gold, M.D.

Panel Discussion/Q & A
Dr. Clare Hochreiter, Chairperson; Drs. Starling, Tajik, Cosgrove, Sarano, Gold, Isom, Borer

RECEPTION


FRIDAY, MAY 3, 2002

Continental breakfast

MITRAL VALVE DISEASE II
Chairman: Richard Brodman, M.D.

Natural history of mitral stenosis and echocardiographic criteria and pitfalls in selecting patients for balloon valvotomy

Ventricular arrhythmias in mitral regurgitation – frequency, importance, management pre and post op
Clare Hochreiter, M.D.

Relation of MR severity, regurgitant volume and sudden death: a “new” risk factor?
Jamil Tajik, M.D.

Surgical correction of AF during mitral valve replacement or repair: results of the Maze procedure
James Cox, M.D.

ACEI/ARB for MR: is this truly appropriate?
Blase Carabello, M.D.

Robotic valve surgery: how does the future look?
Craig Smith, M.D.

Panel Discussion/Q & A
Richard Brodman, M.D., Chairman; Drs. Cox, Smith, Hahn, Hochreiter, Tajik, Carabello

Coffee Break

DISEASES OF THE AORTIC ROOT AND VALVE
Chairman: John Elefteriadis, M.D.

The bicuspid aortic valve: frequency, variations and pathological basis of associated aortic root dilatation
William C. Roberts, M.D.

Perspectives on diseases of the thoracic aorta
John Elefteriadis, M.D.

Valve repair vs replacement when of regurgitation is caused by aortic root aneurysms: relative advantages and disadvantages and impact of decision on surgical indications
Leonard Girardi, M.D.

Panel Discussion/Q & A
Dr. Girardi, Chairman; Drs. Elefteriadis, Roberts, Isom

Buffet Lunch

AORTIC VALVE DISEASE I
Chairman: William C. Roberts, M.D.

Radiolabeled ligand imaging: future role in evaluation and prognostication?
Jagat Narula, M.D., Ph.D.

Criteria for valve surgery in the asymptomatic patient: current standards and effect of rate of change in objective measures?
Jeffrey S. Borer, M.D.

Timing of valve replacement when acute regurgitation results from endocarditis
O. Wayne Isom, M.D.

Results of cholesterol lowering trial for AS
Valentin Fuster, M.D., Ph.D

Panel Discussion/Q & A
Edmund Herrold,M.D., Ph.D. Chairman; Drs. Narula, Roberts, Isom, Fuster, Borer, Stelzer

Coffee Break

AORTIC VALVE DISEASE II
Chairman: Blase Carabello, M.D.

Heart failure in aortic regurgitation: importance and cellular and molecular pathophysiology of primary fibrosis
Jeffrey S. Borer, M.D.

Criteria for operating on the asymptomatic patient: can we defend them?
Alan Schwartz, M.D.

Pitfalls in estimating prosthetic valve function from the echocardiogram


Panel Discussion/Q & A
Paul Stelzer, M.D. Chairman; Schwartz, Roman, Isom, Borer, Carabello

Concluding remarks
Drs. Isom and Borer

Participants complete and submit course evaluation

ADJOURN



 
 
Organized by: The Howard Gilman Institute for Valvular Heart Diseases
Invited Speakers: Course Directors

Jeffrey S. Borer, M.D/Weill Medical College of Cornell University
O. Wayne Isom, M.D./Weill Medical College of Cornell University

Faculty (tentative)

Robert O. Bonow, M.D./Northwestern University Medical School
Richard Brodman, M.D./The Albert Einstein College of Medicine
Blase Carabello, M.D./Baylor College of Medicine
Lawrence Cohn, M.D./Harvard Medical School
James Cox, M.D./Ohio State University School of Medicine
Delos Cosgrove, M.D./The Cleveland Clinic
John Elefteriadis, M.D./Yale University School of Medicine
Valentin Fuster, M.D., Ph.D./Mount Sinai School of Medicine
Aubrey Galloway, M.D./New York University School of Medicine
Timothy Gardner, M.D./University of Pennsylvania School of Medicine
Leonard Girardi, M.D./Weill Medical College of Cornell University
Jeffrey P. Gold, M.D./Albert Einstein College of Medicinety
Edmund Herrold, M.D., Ph.D./Weill Medical College of Cornell University
William Z. Hillenbrand, M.D./Columbia University College of Physicians and Surgeons
Clare Hochreiter, M.D./ Weill Medical College of Cornell University
Karl Krieger, M.D./Weill Medical College of Cornell University
John Lamberti, M.D./Weill Medical College of Cornell University
Jagat Narula, M.D., Ph.D./MCP Hahnemann University
Mehmet Oz, M.D./College of Physicians and Surgeons
Joseph K. Perloff, M.D./UCLA
Jan Quagebeur, M.D/Columbia University College of Physicians and Surgeons
William C. Roberts, M.D./Baylor University Medical Center
Maurice Enrique Sarano, M.D/Mayo Medical School
Allan Schwartz, M.D./ Columbia University College of Physicians and Surgeons
Craig Smith, M.D./ Columbia University College of Physicians and Surgeons
Mark Starling, M.D./University of Michigan Medical School
Paul Stelzer, M.D./Albert Einstein College of Medicine
Phyllis Supino, Ed.D./Weill Medical College of Cornell University
Jamil Tajik, M.D./ Mayo Medical School

 
Deadline for Abstracts: N/A
 
Registration: Early registration (prior to March 9, 2002) – $550
ACC members – $575
Physicians’ Assistants/Nurse Practitioners ¾ $450 (with letter from employer)
Fellows & Residents - $350 (with letter from training director)
All others – $650

E-mail: msljy@lesliejyerman.com
 
  Posted by:   leslie j. yerman  
Host: user-2ivec3d.dialup.mindspring.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2002 HUM-MOLGEN. All rights reserved. Liability and Copyright.